{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:18:01Z","timestamp":1777043881360,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13287-019-1235-8","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T10:11:46Z","timestamp":1558433506000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer"],"prefix":"10.1186","volume":"10","author":[{"given":"Peng","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqun","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinliang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongfeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanghui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoxing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,21]]},"reference":[{"key":"1235_CR1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nature09526","volume":"468","author":"MR Junttila","year":"2010","unstructured":"Junttila MR, Karnezis AN, Garcia D, et al. Selective activation of p53-mediated tumour suppression in high-grade tumours. Nature. 2010;468:567\u201371.","journal-title":"Nature."},{"key":"1235_CR2","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1158\/1541-7786.MCR-10-0052","volume":"8","author":"P Ceppi","year":"2010","unstructured":"Ceppi P, Mudduluru G, Kumarswamy R, et al. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Mol Cancer Res. 2010;8:1207\u201316.","journal-title":"Mol Cancer Res"},{"key":"1235_CR3","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/JTO.0b013e318208c785","volume":"6","author":"KM Foss","year":"2011","unstructured":"Foss KM, Sima C, Ugolini D, et al. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol. 2011;6:482\u20138.","journal-title":"J Thorac Oncol"},{"key":"1235_CR4","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/S0140-6736(16)00587-0","volume":"387","author":"L Fehrenbacher","year":"2016","unstructured":"Fehrenbacher L, Spira A, Ballinger M, et al. Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial. Lancet. 2016;387:1837\u201346.","journal-title":"Lancet."},{"key":"1235_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s12094-011-0656-3","volume":"13","author":"R Perona","year":"2011","unstructured":"Perona R, Lopez-Ayllon BD, de Castro Carpeno J, et al. A role for cancer stem cells in drug resistance and metastasis in non-small-cell lung cancer. Clin Transl Oncol. 2011;13:289\u201393.","journal-title":"Clin Transl Oncol"},{"key":"1235_CR6","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.3892\/or.2015.4163","volume":"34","author":"C Zhao","year":"2015","unstructured":"Zhao C, Setrerrahmane S, Xu H. Enrichment and characterization of cancer stem cells from a human non-small cell lung cancer cell line. Oncol Rep. 2015;34:2126\u201332.","journal-title":"Oncol Rep"},{"key":"1235_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178286","volume":"12","author":"S Holmboe","year":"2017","unstructured":"Holmboe S, Hansen PL, Thisgaard H, et al. Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411. PLoS One. 2017;12:e0178286.","journal-title":"PLoS One"},{"key":"1235_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fonc.2017.00080","volume":"7","author":"N Zakaria","year":"2017","unstructured":"Zakaria N, Satar NA, Abu Halim NH, et al. Targeting lung cancer stem cells: research and clinical impacts. Front Oncol. 2017;7:80.","journal-title":"Front Oncol"},{"key":"1235_CR9","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1158\/1535-7163.MCT-14-0492","volume":"14","author":"FQ Nie","year":"2015","unstructured":"Nie FQ, Sun M, Yang JS, et al. Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression. Mol Cancer Ther. 2015;14:268\u201377.","journal-title":"Mol Cancer Ther"},{"key":"1235_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/cbic.201100487","volume":"13","author":"Y Fu","year":"2012","unstructured":"Fu Y, Ramisetty SR, Hussain N, et al. MBNL1-RNA recognition: contributions of MBNL1 sequence and RNA conformation. Chembiochem. 2012;13:112\u20139.","journal-title":"Chembiochem."},{"key":"1235_CR11","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/carcin\/bgv066","volume":"36","author":"R Tang","year":"2015","unstructured":"Tang R, Qi Q, Wu R, et al. The polymorphic terminal-loop of pre-miR-1307 binding with MBNL1 contributes to colorectal carcinogenesis via interference with Dicer1 recruitment. Carcinogenesis. 2015;36:867\u201375.","journal-title":"Carcinogenesis."},{"key":"1235_CR12","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/JTO.0000000000000470","volume":"10","author":"H Yu","year":"2015","unstructured":"Yu H, Xu Q, Liu F, et al. Identification and validation of long noncoding RNA biomarkers in human non-small-cell lung carcinomas. J Thorac Oncol. 2015;10:645\u201354.","journal-title":"J Thorac Oncol"},{"key":"1235_CR13","doi-asserted-by":"publisher","first-page":"895","DOI":"10.2147\/OTT.S61695","volume":"7","author":"X Mo","year":"2014","unstructured":"Mo X, Zhang F, Liang H, et al. miR-544a promotes the invasion of lung cancer cells by targeting cadherina 1 in vitro. Onco Targets Ther. 2014;7:895\u2013900.","journal-title":"Onco Targets Ther"},{"key":"1235_CR14","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1074\/jbc.M114.617845","volume":"290","author":"T Bertero","year":"2015","unstructured":"Bertero T, Cottrill K, Krauszman A, et al. The microRNA-130\/301 family controls vasoconstriction in pulmonary hypertension. J Biol Chem. 2015;290:2069\u201385.","journal-title":"J Biol Chem"},{"key":"1235_CR15","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s10529-017-2400-8","volume":"39","author":"J Xue","year":"2017","unstructured":"Xue J, Xue J, Zhang J, et al. miR-130b-3p\/301b-3p negatively regulated Rb1cc1 expression on myogenic differentiation of chicken primary myoblasts. Biotechnol Lett. 2017;39:1611\u20139.","journal-title":"Biotechnol Lett"},{"key":"1235_CR16","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/cpr.12264","volume":"49","author":"D Wu","year":"2016","unstructured":"Wu D, Chen B, Cui F, et al. Hypoxia-induced microRNA-301b regulates apoptosis by targeting Bim in lung cancer. Cell Prolif. 2016;49:476\u201383.","journal-title":"Cell Prolif"},{"key":"1235_CR17","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1007\/s13277-014-2861-5","volume":"36","author":"ZL Ma","year":"2015","unstructured":"Ma ZL, Hou PP, Li YL, et al. MicroRNA-34a inhibits the proliferation and promotes the apoptosis of non-small cell lung cancer H1299 cell line by targeting TGFbetaR2. Tumour Biol. 2015;36:2481\u201390.","journal-title":"Tumour Biol"},{"key":"1235_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.lungcan.2007.04.019","volume":"58","author":"JB Xu","year":"2007","unstructured":"Xu JB, Bao Y, Liu X, et al. Defective expression of transforming growth factor beta type II receptor (TGFBR2) in the large cell variant of non-small cell lung carcinoma. Lung Cancer. 2007;58:36\u201343.","journal-title":"Lung Cancer"},{"key":"1235_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4103\/0022-3859.52846","volume":"55","author":"KS Puri","year":"2009","unstructured":"Puri KS, Suresh KR, Gogtay NJ, et al. Declaration of Helsinki, 2008: implications for stakeholders in research. J Postgrad Med. 2009;55:131\u20134.","journal-title":"J Postgrad Med"},{"issue":"Suppl 1","key":"1235_CR20","doi-asserted-by":"publisher","first-page":"E231","DOI":"10.1002\/hed.23975","volume":"38","author":"CC Yu","year":"2016","unstructured":"Yu CC, Hu FW, Yu CH, et al. Targeting CD133 in the enhancement of chemosensitivity in oral squamous cell carcinoma-derived side population cancer stem cells. Head Neck. 2016;38(Suppl 1):E231\u20138.","journal-title":"Head Neck"},{"key":"1235_CR21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13046-018-0894-0","volume":"37","author":"S Cao","year":"2018","unstructured":"Cao S, Wang Z, Gao X, et al. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC. J Exp Clin Cancer Res. 2018;37:220.","journal-title":"J Exp Clin Cancer Res"},{"key":"1235_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.freeradbiomed.2011.11.003","volume":"52","author":"AI Rojo","year":"2012","unstructured":"Rojo AI, Medina-Campos ON, Rada P, et al. Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: role of glycogen synthase kinase-3. Free Radic Biol Med. 2012;52:473\u201387.","journal-title":"Free Radic Biol Med"},{"key":"1235_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep41670","volume":"7","author":"H Yang","year":"2017","unstructured":"Yang H, Zhang H, Zhong Y, et al. Concomitant underexpression of TGFBR2 and overexpression of hTERT are associated with poor prognosis in cervical cancer. Sci Rep. 2017;7:41670.","journal-title":"Sci Rep"},{"key":"1235_CR24","doi-asserted-by":"publisher","first-page":"7447","DOI":"10.1002\/jcp.26590","volume":"233","author":"R Wang","year":"2018","unstructured":"Wang R, Dong HX, Zeng J, et al. LncRNA DGCR5 contributes to CSC-like properties via modulating miR-330-5p\/CD44 in NSCLC. J Cell Physiol. 2018;233:7447\u201356.","journal-title":"J Cell Physiol"},{"key":"1235_CR25","first-page":"8881","volume":"7","author":"X Xie","year":"2014","unstructured":"Xie X, Liu HT, Mei J, et al. LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis. Int J Clin Exp Pathol. 2014;7:8881\u20136.","journal-title":"Int J Clin Exp Pathol"},{"key":"1235_CR26","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1186\/s12885-016-2569-6","volume":"16","author":"PC Lin","year":"2016","unstructured":"Lin PC, Huang HD, Chang CC, et al. Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2. BMC Cancer. 2016;16:583.","journal-title":"BMC Cancer"},{"key":"1235_CR27","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.canlet.2016.08.029","volume":"382","author":"J Lv","year":"2016","unstructured":"Lv J, Fan HX, Zhao XP, et al. Long non-coding RNA Unigene56159 promotes epithelial-mesenchymal transition by acting as a ceRNA of miR-140-5p in hepatocellular carcinoma cells. Cancer Lett. 2016;382:166\u201375.","journal-title":"Cancer Lett"},{"key":"1235_CR28","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.cca.2010.02.074","volume":"411","author":"JG Zhang","year":"2010","unstructured":"Zhang JG, Wang JJ, Zhao F, et al. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta. 2010;411:846\u201352.","journal-title":"Clin Chim Acta"},{"key":"1235_CR29","doi-asserted-by":"publisher","first-page":"693","DOI":"10.4103\/0973-1482.146130","volume":"12","author":"YK Shi","year":"2016","unstructured":"Shi YK, Zang QL, Li GX, et al. Increased expression of microRNA-301a in nonsmall-cell lung cancer and its clinical significance. J Cancer Res Ther. 2016;12:693\u20138.","journal-title":"J Cancer Res Ther"},{"key":"1235_CR30","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1158\/1078-0432.CCR-0959-3","volume":"10","author":"HT Zhang","year":"2004","unstructured":"Zhang HT, Chen XF, Wang MH, et al. Defective expression of transforming growth factor beta receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer. Clin Cancer Res. 2004;10:2359\u201367.","journal-title":"Clin Cancer Res"},{"key":"1235_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40164-018-0102-0","volume":"7","author":"RS Fort","year":"2018","unstructured":"Fort RS, Matho C, Oliveira-Rizzo C, et al. An integrated view of the role of miR-130b\/301b miRNA cluster in prostate cancer. Exp Hematol Oncol. 2018;7:10.","journal-title":"Exp Hematol Oncol"},{"key":"1235_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s12276-018-0133-y","volume":"50","author":"XF Li","year":"2018","unstructured":"Li XF, Wang ZQ, Li LY, et al. Downregulation of the long noncoding RNA MBNL1-AS1 protects sevoflurane-pretreated mice against ischemia-reperfusion injury by targeting KCNMA1. Exp Mol Med. 2018;50:115.","journal-title":"Exp Mol Med"},{"key":"1235_CR33","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/1759-7714.12652","volume":"9","author":"L Wang","year":"2018","unstructured":"Wang L, Ma L, Xu F, et al. Role of long non-coding RNA in drug resistance in non-small cell lung cancer. Thorac Cancer. 2018;9:761\u20138.","journal-title":"Thorac Cancer"},{"key":"1235_CR34","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3892\/ijo.2014.2243","volume":"44","author":"N Funamizu","year":"2014","unstructured":"Funamizu N, Lacy CR, Parpart ST, et al. MicroRNA-301b promotes cell invasiveness through targeting TP63 in pancreatic carcinoma cells. Int J Oncol. 2014;44:725\u201334.","journal-title":"Int J Oncol"},{"key":"1235_CR35","first-page":"6017","volume":"14","author":"Z Wu","year":"2017","unstructured":"Wu Z, Li Y, Zhang G. Downregulation of microRNA-301a inhibited proliferation, migration and invasion of non-small cell lung cancer by directly targeting DLC1. Oncol Lett. 2017;14:6017\u201323.","journal-title":"Oncol Lett"},{"key":"1235_CR36","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1139\/bcb-2016-0232","volume":"95","author":"L Yan","year":"2017","unstructured":"Yan L, Wang Y, Liang J, et al. MiR-301b promotes the proliferation, mobility, and epithelial-to-mesenchymal transition of bladder cancer cells by targeting EGR1. Biochem Cell Biol. 2017;95:571\u20137.","journal-title":"Biochem Cell Biol"},{"key":"1235_CR37","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.biopha.2017.11.105","volume":"96","author":"G Li","year":"2017","unstructured":"Li G, Wu F, Yang H, et al. MiR-9-5p promotes cell growth and metastasis in non-small cell lung cancer through the repression of TGFBR2. Biomed Pharmacother. 2017;96:1170\u20138.","journal-title":"Biomed Pharmacother"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-019-1235-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-019-1235-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-019-1235-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T23:23:01Z","timestamp":1589930581000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-019-1235-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,21]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1235"],"URL":"https:\/\/doi.org\/10.1186\/s13287-019-1235-8","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,21]]},"assertion":[{"value":"10 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed with the approval of the Ethics Committee of The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital. All patients signed informed consents prior to tissue collection, which was in compliance with the Declaration of Helsinki []. Moreover, the animal experiment procedures were performed in accordance with the protocols issued by the Institutional Animal Research Committee of The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital. Measures were taken to minimize animal suffering.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The consent for publication has been obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"144"}}